Effects of Early Short-Course Corticosteroids on Immune-Related Adverse Events in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors
Journal
Oncology
Journal Volume
102
Journal Issue
4
Date Issued
2023-09
Abstract
In real-world practice, most non-small cell lung cancer (NSCLC) patients receiving combined immunochemotherapy are exposed to short-course corticosteroids following immune checkpoint inhibitor (ICI) infusion to prevent chemotherapy-related adverse events. However, whether this early short-course corticosteroid use prevents immune-related adverse events (irAEs) remains unknown.
Subjects
Corticosteroid; Immune checkpoint inhibitors; Immune-related adverse events; Non-small cell lung cancer
SDGs
Type
journal article